Liliana Endo-Munoz
Liliana Endo-Munoz
Honorary Fellow, The University of Queensland Diamantina Institute
Verified email at - Homepage
Cited by
Cited by
Role of intratumoural heterogeneity in cancer drug resistance: molecular and clinical perspectives
NA Saunders, F Simpson, EW Thompson, MM Hill, L Endo‐Munoz, ...
EMBO molecular medicine 4 (8), 675-684, 2012
The role of osteoclasts and tumour-associated macrophages in osteosarcoma metastasis
L Endo-Munoz, A Evdokiou, NA Saunders
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1826 (2), 434-442, 2012
Phosphorylation of HIV Tat by PKR increases interaction with TAR RNA and enhances transcription
L Endo-Munoz, T Warby, D Harrich, NAJ McMillan
Virology journal 2 (1), 1-13, 2005
E2F7 can regulate proliferation, differentiation, and apoptotic responses in human keratinocytes: implications for cutaneous squamous cell carcinoma formation
L Endo-Munoz, A Dahler, N Teakle, D Rickwood, M Hazar-Rethinam, ...
Cancer research 69 (5), 1800-1808, 2009
Loss of osteoclasts contributes to development of osteosarcoma pulmonary metastases
L Endo-Munoz, A Cumming, D Rickwood, D Wilson, C Cueva, C Ng, ...
Cancer research 70 (18), 7063-7072, 2010
Preclinical evaluation of dual PI3K-mTOR inhibitors and histone deacetylase inhibitors in head and neck squamous cell carcinoma
RB Erlich, Z Kherrouche, D Rickwood, L Endo-Munoz, S Cameron, ...
British Journal of Cancer 106 (1), 107-115, 2012
Osteosarcoma is characterised by reduced expression of markers of osteoclastogenesis and antigen presentation compared with normal bone
L Endo-Munoz, A Cumming, S Sommerville, I Dickinson, NA Saunders
British journal of cancer 103 (1), 73-81, 2010
Dysregulation of the repressive H3K27 trimethylation mark in head and neck squamous cell carcinoma contributes to dysregulated squamous differentiation
OM Gannon, LM de Long, L Endo-Munoz, M Hazar-Rethinam, ...
Clinical Cancer Research 19 (2), 428-441, 2013
Stepwise pore size reduction of ordered nanoporous silica materials at angstrom precision
S Jambhrunkar, M Yu, J Yang, J Zhang, A Shrotri, L Endo-Munoz, ...
Journal of the American Chemical Society 135 (23), 8444-8447, 2013
Progression of osteosarcoma from a non-metastatic to a metastatic phenotype is causally associated with activation of an autocrine and paracrine uPA axis
L Endo-Munoz, N Cai, A Cumming, R Macklin, L Merida de Long, ...
PLoS One 10 (8), e0133592, 2015
Extracellular vesicles secreted by highly metastatic clonal variants of osteosarcoma preferentially localize to the lungs and induce metastatic behaviour in poorly metastatic …
R Macklin, H Wang, D Loo, S Martin, A Cumming, N Cai, R Lane, ...
Oncotarget 7 (28), 43570, 2016
Auranofin is a potent suppressor of osteosarcoma metastasis
E Topkas, N Cai, A Cumming, M Hazar-Rethinam, OM Gannon, ...
Oncotarget 7 (1), 831, 2016
A novel E2F/sphingosine kinase 1 axis regulates anthracycline response in squamous cell carcinoma
M Hazar-Rethinam, LM de Long, OM Gannon, E Topkas, S Boros, ...
Clinical Cancer Research 21 (2), 417-427, 2015
Tumor-initiating activity and tumor morphology of HNSCC is modulated by interactions between clonal variants within the tumor
SR Cameron, AL Dahler, LB Endo-Munoz, I Jabbar, GP Thomas, PJ Leo, ...
Laboratory investigation 90 (11), 1594-1603, 2010
Focal overexpression of CEACAM6 contributes to enhanced tumourigenesis in head and neck cancer via suppression of apoptosis
S Cameron, LM de Long, M Hazar-Rethinam, E Topkas, L Endo-Munoz, ...
Molecular cancer 11 (1), 1-11, 2012
The role of the E2F transcription factor family in UV-induced apoptosis
M Hazar-Rethinam, L Endo-Munoz, O Gannon, N Saunders
International journal of molecular sciences 12 (12), 8947-8960, 2011
Loss of E2F7 expression is an early event in squamous differentiation and causes derepression of the key differentiation activator Sp1
M Hazar-Rethinam, SR Cameron, AL Dahler, LB Endo-Munoz, L Smith, ...
Journal of investigative dermatology 131 (5), 1077-1084, 2011
A western blot to detect antibody to avian reovirus
LB Endo‐Munoz
Avian pathology 19 (3), 477-487, 1990
Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with high-risk resected melanoma
JS Cebon, M Gore, JF Thompson, ID Davis, GA McArthur, E Walpole, ...
Journal for immunotherapy of cancer 8 (1), 2020
Merida de Long L., Topkas E., Mukhopadhyay P., Hill M., Saunders NA Progression of osteosarcoma from a non-metastatic to a metastatic phenotype is causally associated with …
L Endo-Munoz, N Cai, A Cumming, R Macklin
PLoS One 10 (8), 2015
The system can't perform the operation now. Try again later.
Articles 1–20